Adopting RWE Adaptive Study Design & Synthetic Control Arms for Multi-Cancer Early Detection Rates

Time: 8:30 am
day: Day Two

Details:

  • Exploring how RWE studies can provide clinical validity/utility outcomes encompassing a large number of subjects in the intended use population of multi-cancer early detection tests (liquid biopsy), including those with rare cancers
  • Understanding how such studies can give information reflective of the real-world population setting about diagnoses, screening frequencies, biopsy compliance, and treatment patterns, including those that may evolve over time
  • Adaptive study designs with cohort matching, including standard or care synthetic control arms

Speakers: